Akemi Thakshila Wijayabahu

Dr. Akemi Thakshila Wijayabahu

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2024 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
AWAkemi Thakshila Wijayabahu
Akemi Thakshila Wijayabahu
MSMeredith S. Shiels
Meredith S. Shiels
RARebecca C. Arend
Rebecca C. Arend
MCMegan A. Clarke
Megan A. Clarke

2 November 2020 in Brain, Behavior, & Immunity - Health
Verified
Journal Article
Open access
SRShannan Rich
Shannan Rich
EKEmily Klann
Emily Klann
VBVaughn Bryant
Vaughn Bryant
VRVeronica Richards
Veronica Richards
AWAkemi Thakshila Wijayabahu
Akemi Thakshila Wijayabahu
RCRobert Cook
Robert Cook
The microbiome-gut-brain axis, or the various interactions between the gut microbiome and the brain, has been of recent interest in the context of precision medicine research for a variety of disease states. Persons living with human immunodeficiency virus (PLWH) experience higher degrees of neurocognitive decline than the general population, correlating with a disruption of the normal gut microbiome composition (i.e. dysbiosis). While the nature of this correlation remains to be determined, there is the potential that the microbiome-gut-brain axis contributes to the progression of this disease. Previous research has established that the pathology associated with HIV induces alterations in the composition of gut microbiome, including a shift from Bacteroides to Prevotella dominance, and compromises gut barrier integrity, which may promote microbial translocation and consequent systemic inflammation and exacerbation of neuroinflammation. Further, though the use of antiretroviral therapy has been found to partially counteract HIV-related dysbiosis, it may also induce its own dysbiosis patterns, presenting a unique challenge for this research.

7 March 2019 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
AWAkemi Thakshila Wijayabahu
Akemi Thakshila Wijayabahu
SWSheldon G. Waugh
Sheldon G. Waugh
MUMaria Ukhanova
Maria Ukhanova
VMVolker Mai
Volker Mai
Dried fruits, such as raisins, contain phytochemicals and dietary fibers that contribute to maintaining health, potentially at least partially through modification in gut microbiota composition and activities. However, the effects of raisin consumption on gut microbiota have not previously been thoroughly investigated in humans. Therefore, the objective of this study was to determine how adding three servings of sun dried raisin/day to the diet of healthy volunteers affects gut microbiota composition. A 14-day exploratory feeding study was conducted with thirteen healthy individuals between the ages of 18 and 59 years. Participants consumed three servings (28.3 g each) of sun dried raisins daily. Fecal samples were collected prior to raisin consumption (baseline) and after the addition of raisins to the diet (on days 7 and 14). To determine the effects of raisin intake, fecal microbiota composition before and after raisin consumption was characterized for each participant by 16S rRNA gene sequencing. Overall microbiota diversity was not significantly affected by adding raisins to the diet. However, upon addition of raisins to the diet specific OTUs matching Faecalibacterium prausnitzii, Bacteroidetes sp. and Ruminococcus sp. increased in prevalence while OTUs closest to Klebsiella sp., Prevotella sp. and Bifidobacterium spp. decreased. Our findings suggest that adding raisins to the diet can affect the prevalence of specific bacterial taxa. Potential health benefits of the observed microbiota changes should be determined in future studies in populations for which specific health outcomes can be targeted. http://www.clinicaltrials.gov ; Identifier: NCT02713165 .

26 March 2024 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
THTalar S. Habeshian
Talar S. Habeshian
NPNoah C. Peeri
Noah C. Peeri
Immaculata De VivoImmaculata De Vivo
Immaculata De Vivo
Leo SchoutenLeo Schouten
Leo Schouten
XSXiao-Ou Shu
Xiao-Ou Shu
VSVeronica Wendy Setiawan
Veronica Wendy Setiawan
Background: The incidence rates of endometrial cancer are increasing, which may partly be explained by the rising prevalence of obesity, an established risk factor for endometrial cancer. Hypertension, another component of metabolic syndrome, is also increasing in prevalence, and emerging evidence suggests that it may be associated with the development of certain cancers. The role of hypertension independent of other components of metabolic syndrome in the etiology of endometrial cancer remains unclear. In this study, we evaluated hypertension as an independent risk factor for endometrial cancer and whether this association is modified by other established risk factors. Methods: We included 15,631 endometrial cancer cases and 42,239 controls matched on age, race, and study-specific factors from 29 studies in the Epidemiology of Endometrial Cancer Consortium. We used multivariable unconditional logistic regression models to estimate ORs and 95% confidence intervals (CI) to evaluate the association between hypertension and endometrial cancer and whether this association differed by study design, race/ethnicity, body mass index, diabetes status, smoking status, or reproductive factors. Results: Hypertension was associated with an increased risk of endometrial cancer (OR, 1.14; 95% CI, 1.09–1.19). There was significant heterogeneity by study design (Phet < 0.01), with a stronger magnitude of association observed among case–control versus cohort studies. Stronger associations were also noted for pre-/perimenopausal women and never users of postmenopausal hormone therapy. Conclusions: Hypertension is associated with endometrial cancer risk independently from known risk factors. Future research should focus on biologic mechanisms underlying this association. Impact: This study provides evidence that hypertension may be an independent risk factor for endometrial cancer.

10 December 2022 in Nutrition
Verified
Journal Article
Closed access
Dongyu ZhangDongyu Zhang
Dongyu Zhang
KSKori A. Spiropoulos
Kori A. Spiropoulos
AWAkemi Thakshila Wijayabahu
Akemi Thakshila Wijayabahu
DCDemetra D. Christou
Demetra D. Christou
SKShama D Karanth
Shama D Karanth
DBDejana Braithwaite
Dejana Braithwaite

2 January 2020 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
AWAkemi Thakshila Wijayabahu
Akemi Thakshila Wijayabahu
KEKathleen M. Egan
Kathleen M. Egan
LYLusine Yaghjyan
Lusine Yaghjyan